NGLY1 mutation causes neuromotor impairment, intellectual disability, and neuropathy
Ahmet Okay Çağlayan(Dokuz Eylül University), Murat Günel(Yale University), Hudson H. Freeze(Discovery Institute), Gozde Akgumus(Yale University), Caner Çağlar(Rockefeller University), Ketu Mishra-Gorur(Yale University), Sinan Çomu(Memorial Sisli Hospital), Kaya Bilgüvar(Yale Cancer Center), Jacob F. Baranoski(Barrow Neurological Institute), Akdes Serin Harmancı(Baylor College of Medicine), Hande Kaymakçalan(Istanbul Bilim University), Emine Zeynep Erson-Omay(Yale University), Duygu Dölen(Yale University), Yeşim Parman(Université Paris-Sud), Katsuhito Yasuno(Yale Cancer Center)
Cited by 89
Related Papers
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
|New England Journal of Medicine|2018|2.9k
Essentials of Glycobiology
|Unknown|1999|2.5k
Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A
|Nature Genetics|2004|1.6k